What Are Muscle Damage Markers?

Muscle damage markers are circulating proteins and enzymes used as indirect indices of skeletal-muscle disruption. The two most commonly reported in the registered studies cited here are lactate dehydrogenase (LDH) and creatine kinase (CK), both of which appear in the outcome lists of exercise-intervention trials [1]. They are not structural components of the contractile apparatus in the way that myosin or actin are; they are intracellular enzymes that leak into plasma when sarcolemmal integrity is compromised, which is why they are described as markers rather than as mediators of damage.

Synonyms in the literature include "muscle damage biomarkers," "exercise-induced muscle damage markers," and "muscle injury markers." The class is heterogeneous: CK and LDH are enzymes, whereas other markers used alongside them in the same panels are lipid-peroxidation products (malondialdehyde, F2-isoprostanes), oxidative DNA adducts (8-OHdG), inflammatory cytokines (IL-6, MCP-1), and acute-phase proteins (hsCRP) [1]. The evidence block does not supply a sequence, molecular formula, or molecular weight for LDH or CK, and none is asserted here. The mechanistic work in this area centres on the antioxidant and inflammatory signalling axis — specifically the balance between reactive oxygen species generation during eccentric contraction and the endogenous antioxidant enzyme system (superoxide dismutase, catalase, glutathione peroxidase) that the same study panels measure [1].

Research Studies

Pterostilbene cocrystal with silybin and nicotinamide riboside and post-exercise muscle damage markers

A registered trial is evaluating a dietary supplement designated ccPT-SIL-NR, containing pterostilbene (ccPT), silybin (SIL), and nicotinamide riboside (NR), in the context of a high-intensity exercise session [1]. The primary objective is change in blood malondialdehyde (MDA) levels. Muscle damage markers (LDH, CK) are listed among the secondary objectives, alongside oxidative DNA damage (8-OHdG), lipid peroxidation (F2-isoprostanes), total antioxidant capacity by FRAP assay, the glutathione ratio (GSH/GSSG), antioxidant enzyme activity (SOD, CAT, GPx), inflammatory markers (hsCRP, MCP-1, IL-6), cortisol, renal function (creatinine), and gene expression [1]. The design therefore treats LDH and CK as one component of a broader oxidative-stress and inflammation panel rather than as standalone endpoints.

Astaxanthin and muscle damage markers after eccentric arm exercise

Astaxanthin (AX) is described in the registered record as a potent antioxidant and anti-inflammatory carotenoid [2]. Prior research examining whether AX could counteract exercise-induced muscle damage and improve exercise capacity was reported to have produced inconsistent results, which motivated the study in question [2]. That study explored the impact of four weeks of AX supplementation on muscle damage markers, total antioxidant status, and a subjective marker of muscle pain [2].

Twenty-four males were randomly assigned across the three groups [2]. After four weeks of supplementation, blood samples were collected at rest, immediately after, and at 2, 24, 48, and 72 hours following eccentric arm exercise [2]. The sampling schedule is the informative part for anyone reading the marker literature: CK and LDH do not peak at a single uniform time point, which is why serial draws rather than a single post-exercise sample are used to characterise the response.

Chickpea protein hydrolysate and muscle damage markers during a football tournament

A randomized, placebo-controlled crossover study evaluated the safety and potential beneficial effects of a beverage containing chickpea protein hydrolysate in football players [3]. Participants received the chickpea protein hydrolysate beverage and a matched protein-containing placebo beverage during two four-week intervention periods separated by a two-week washout period [3]. The assessed outcomes included biochemical safety parameters, antioxidant status, inflammatory biomarkers, lipid profile, lipid peroxidation, muscle damage markers, dietary intake, and body composition [3]. The crossover structure means each participant served as their own comparator across the two periods, which is relevant when the outcome is a marker with substantial between-individual variability.

Why LDH and CK are reported together

LDH and CK are grouped in the outcome panels of all three registered studies cited here [1][2][3]. They are not interchangeable. CK is the more muscle-specific of the two; LDH is expressed across many tissues, so an isolated LDH elevation is a less specific signal. The studies do not resolve this limitation — they report both, and the interpretation of a divergence between them is not addressed in the evidence provided.

Muscle damage markers as secondary, not primary, endpoints

In the ccPT-SIL-NR trial, LDH and CK are explicitly secondary objectives, subordinate to the primary MDA endpoint [1]. In the astaxanthin study, muscle damage markers are named as an exploratory target alongside total antioxidant status and subjective muscle pain [2]. In the chickpea protein hydrolysate study, muscle damage markers sit within a broad safety-and-efficacy panel that also includes lipid profile and body composition [3]. Across all three, the marker is a downstream readout of an intervention, not the intervention's mechanism.

What the evidence does not establish

None of the three registered records cited here reports a completed result for muscle damage markers. The evidence block contains study descriptions and outcome lists, not effect sizes, confidence intervals, or between-group differences. No claim is made here that any of the compounds discussed reduces, prevents, or attenuates muscle damage marker elevation, because the evidence provided does not support such a claim. The astaxanthin record notes that prior research in this area reported inconsistent results [2], which is a statement about the state of the literature, not a finding of the study itself.

Species and model scope

All three studies cited are human exercise-intervention studies: the ccPT-SIL-NR trial uses a high-intensity exercise session [1], the astaxanthin study uses eccentric arm exercise in twenty-four males [2], and the chickpea protein hydrolysate study uses football players during a tournament [3]. No animal-only or in vitro data on muscle damage markers is supplied in the evidence block, and none is described here. Where the broader marker literature includes cell-culture and rodent work, that material is outside the scope of the sources cited on this page.

Measurement timing as a design variable

The astaxanthin study's sampling schedule — rest, immediately after, and 2, 24, 48, and 72 hours post-exercise — illustrates that the reported value of a muscle damage marker depends on when the sample is drawn [2]. A study reporting a single post-exercise time point and a study reporting a 72-hour curve are not directly comparable even if they use the same assay. The ccPT-SIL-NR and chickpea protein hydrolysate records do not specify their sampling schedules in the evidence provided [1][3].

If you are reading this for personal health reasons

The materials described on this page are sold for laboratory research use only. We do not provide dosing information, medical guidance, or recommendations for human use. Anyone considering a compound for themselves should speak to a licensed clinician.

Sources

• [1] Effect of the Combination of Pterostilbene Cocrystal With Silybin and Nicotinamide Riboside on Exercise-Induced Oxidative Stress — ClinicalTrials.gov
• [2] Effects of Astaxanthin Supplementation — ClinicalTrials.gov
• [3] Effect of Chickpea Protein Hydrolysate Supplementation on Muscle Damage and Inflammatory Plasma Markers During a Football Tournament: A Randomized, Placebo-Controlled Crossover Trial — ClinicalTrials.gov